Who makes Cagrilintide and Semaglutide?

Cagrilintide and Semaglutide is developed by Novo Nordisk A/S.

What development phase is Cagrilintide and Semaglutide in?

Cagrilintide and Semaglutide is in Phase 1.

Last reviewed 2026-05-14 · How we verify

Cagrilintide and Semaglutide

Novo Nordisk A/S · Phase 1 active Small molecule

At a glance

Generic name	Cagrilintide and Semaglutide
Sponsor	Novo Nordisk A/S
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Cagrilintide and Semaglutide CI brief — competitive landscape report
Cagrilintide and Semaglutide updates RSS · CI watch RSS
Novo Nordisk A/S portfolio CI